Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 9
2003 2
2004 5
2005 13
2006 5
2007 9
2008 9
2009 7
2010 7
2011 10
2012 10
2013 21
2014 10
2015 11
2016 27
2017 25
2018 33
2019 28
2020 45
2021 51
2022 44
2023 41
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

388 results

Results by year

Filters applied: . Clear all
Page 1
Patient-Initiated Follow-Up.
Alveyn E, Galloway J, Coates LC. Alveyn E, et al. Among authors: galloway j. J Rheumatol. 2024 Apr 15:jrheum.2024-0302. doi: 10.3899/jrheum.2024-0302. Online ahead of print. J Rheumatol. 2024. PMID: 38621794
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.
Brown AD, Fisher L, Curtis HJ, Wiedemann M, Hulme WJ, Speed V, Hopcroft LEM, Cunningham C, Costello RE, Galloway JB, Russell MD, Bechman K, Kurt Z, Croker R, Wood C, Walker AJ, Schaffer AL, Bacon SCJ, Mehrkar A, Hickman G, Bates C, Cockburn J, Parry J, Hester F, Harper S, Goldacre B; OpenSAFELY Collaborative; MacKenna B. Brown AD, et al. Among authors: galloway jb. Br J Clin Pharmacol. 2024 Apr 8. doi: 10.1111/bcp.16062. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 38589944
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Cope AP, Jasenecova M, Vasconcelos JC, Filer A, Raza K, Qureshi S, D'Agostino MA, McInnes IB, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga T, Toes R, Georgiou E, Kelly J, Murphy C, Prevost AT; APIPPRA study investigators. Cope AP, et al. Lancet. 2024 Mar 2;403(10429):838-849. doi: 10.1016/S0140-6736(23)02649-1. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364839 Free article. Clinical Trial.
The influence of safety warnings on the prescribing of JAK inhibitors.
Russell MD, Yang Z, Walter B, Alveyn E, Bechman K, Miracle A, Nagra D, Adas MA, Norton S, Cope AP, Langan SM, Galloway JB. Russell MD, et al. Among authors: galloway jb. Lancet Rheumatol. 2024 Mar;6(3):e138-e139. doi: 10.1016/S2665-9913(24)00002-X. Epub 2024 Feb 1. Lancet Rheumatol. 2024. PMID: 38310922 No abstract available.
388 results